Unknown

Dataset Information

0

Naturally processed non-canonical HLA-A*02:01 presented peptides.


ABSTRACT: Human leukocyte antigen (HLA) class I molecules generally present peptides (p) of 8 to 11 amino acids (aa) in length. Although an increasing number of examples with lengthy (>11 aa) peptides, presented mostly by HLA-B alleles, have been reported. Here we characterize HLA-A*02:01 restricted, in addition to the HLA-B*0702 and HLA-B*4402 restricted, lengthy peptides (>11 aa) arising from the B-cell ligandome. We analyzed a number of 15-mer peptides presented by HLA-A*02:01, and confirmed pHLA-I formation by HLA folding and thermal stability assays. Surprisingly the binding affinity and stability of the 15-mer epitopes in complex with HLA-A*02:01 were comparable with the values observed for canonical length (8 to 11 aa) HLA-A*02:01-restricted peptides. We solved the structures of two 15-mer epitopes in complex with HLA-A*02:01, within which the peptides adopted distinct super-bulged conformations. Moreover, we demonstrate that T-cells can recognize the 15-mer peptides in the context of HLA-A*02:01, indicating that these 15-mer peptides represent immunogenic ligands. Collectively, our data expand our understanding of longer epitopes in the context of HLA-I, highlighting that they are not limited to the HLA-B family, but can bind the ubiquitous HLA-A*02:01 molecule, and play an important role in T-cell immunity.

SUBMITTER: Hassan C 

PROVIDER: S-EPMC4317018 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications


Human leukocyte antigen (HLA) class I molecules generally present peptides (p) of 8 to 11 amino acids (aa) in length. Although an increasing number of examples with lengthy (>11 aa) peptides, presented mostly by HLA-B alleles, have been reported. Here we characterize HLA-A*02:01 restricted, in addition to the HLA-B*0702 and HLA-B*4402 restricted, lengthy peptides (>11 aa) arising from the B-cell ligandome. We analyzed a number of 15-mer peptides presented by HLA-A*02:01, and confirmed pHLA-I for  ...[more]

Similar Datasets

| S-EPMC10943130 | biostudies-literature
| S-EPMC8100314 | biostudies-literature
| S-EPMC6593758 | biostudies-literature
| S-EPMC2787804 | biostudies-literature
| S-EPMC5685222 | biostudies-literature
| S-EPMC5407724 | biostudies-literature
2024-03-20 | PXD043989 | Pride
| S-EPMC8247313 | biostudies-literature
| S-EPMC7825995 | biostudies-literature
| S-EPMC7956451 | biostudies-literature